Word

DC PHARMA

Status

Registered

Status Code

700

Status Date

Tuesday, June 25, 2024

Serial Number

79366207

Registration Number

7423994

Registration Date

Tuesday, June 25, 2024

Mark Type

3

Filing Date

Friday, February 10, 2023

Published for Opposition

Tuesday, April 9, 2024

Trademark Owner History

YANTAI DONGCHENG BIOCHEMICALS CO., LTD. - Original Registrant

Classifications

5 Diagnostic radiopharmaceutical preparations; vitamin tablets; medicines for human purposes, namely, medicines for the treatment of diabetes, obesity, cancer, oncological diseases, cardiovascular and cerebrovascular diseases, colds, cough, influenza, respiratory diseases and asthma, gastrointestinal diseases, genitourinary diseases, neurological diseases, allergies, headaches, insomnia, bacteria-based diseases, ocular disorders or diseases; biochemical medicines for the treatment of cancer; liquid herbal supplements; medicinal drinks; capsules sold empty for pharmaceuticals; pharmaceutical preparations, namely, antivirals; radioactive substances for medical purposes; pharmaceutical preparations for treating chemical imbalances; mixed biological preparations for the prevention and treatment of infectious diseases; isotopes for medical purposes; diagnostic reagents for medicinal use; diagnostic preparations for medical purposes; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; injectable pharmaceuticals for treatment of anaphylactic reactions; medicines made of Chinese traditional medicinal herbs; dietary supplements

The mark consists of four Chinese characters and stylized letters "DC PHARMA" to the right and a design of two semicircles of irregular shapes to the left.
The non-Latin characters in the mark transliterate from left to right to "DONG", "CHENG", "YAO" and "YE". The four non-Latin characters may be translated into English as "East", "Honest", "Medicine" and "Industry". The whole combination conveys no special meaning.
"PHARMA" and the non-Latin characters that transliterate to "YAO" and "YE,"

Trademark Events

Apr 2, 2023

New Application Office Supplied Data Entered

Apr 6, 2023

Application Filing Receipt Mailed

Nov 9, 2023

Assigned To Examiner

Mar 30, 2023

Sn Assigned For Sect 66a Appl From Ib

Mar 30, 2023

Limitation From Original Application Entered

Nov 22, 2023

Non-Final Action Written

Nov 23, 2023

Non-Final Action (Ib Refusal) Prepared For Review

Nov 28, 2023

Non-Final Action Mailed - Refusal Sent To Ib

Dec 19, 2023

Refusal Processed By Ib

Feb 21, 2024

Teas/Email Correspondence Entered

Feb 21, 2024

Correspondence Received In Law Office

Feb 21, 2024

Teas Response To Office Action Received

Nov 28, 2023

Refusal Processed By Mpu

Mar 1, 2024

Approved For Pub - Principal Register

Mar 20, 2024

Notification Of Notice Of Publication E-Mailed

Mar 27, 2024

Notification Of Possible Opposition Sent To Ib

Mar 27, 2024

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Apr 9, 2024

Published For Opposition

Apr 9, 2024

Official Gazette Publication Confirmation E-Mailed

Jun 25, 2024

Registered-Principal Register

Jun 25, 2024

Notice Of Registration Confirmation Emailed

Apr 16, 2024

Notification Processed By Ib